guiding and enabling cutting edge drug development for the pharmaceutical industry.
leading the customer through early-stage product development research as well as fully customised in-vivo and in-vitro studies.
enhancing its research projects by including best-of-breed experts from its international network.
because its team strongly believes that good science and good animal welfare are two sides of the same coin.
making every effort to take its customers a wingstroke ahead.
Profit from Aurigon’s long-standing expertise in the development of small molecules
Whether you are looking for consultancy or support for individual studies, Aurigon experts are there to help.
Dear Customer,
We are pleased to inform you that as of October 01, 2023, the form and name of our company officially will change from ATRC Aurigon Toxicological Research Center LLC to Aurigon Labs Ltd.
Our seat, facilities, labs, GLP certificates, staff, management, etc. are going to be the same.
Any existing contracts, agreements, or ongoing projects will remain valid under the new company name, and you can expect the same high level professional services and expertise from us as you are used to.
Thank you for your continued trust and partnership!
With best regards,
Dr. István Gacsályi
CEO